๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer
NCT06592287Advanced Gastric Cancer
Xianglin Yuan
Phase 1/2
66
Wuhan
2024-09-30
Recruiting
Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
NCT06609304Lymphoma, B-Cell
Zhengzhou University
Phase 4
20
Zhengzhou
2024-09-30
Recruiting
Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma
NCT07243626Soft Tissue Sarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hanzhong
2024-09-30
Active, closed
Pulsed-Field Ablation With/Without Electrogram Mapping
NCT07541989Non-paroxysmal Atrial Fibrillation
Xu Liu
Not applicable
300
Wuhan, Changshu, Xuzhou, Jinan, Wenling, Yuhuan, Shanghai
2024-09-30
Recruiting
Neoadjuvant Triple Therapy for Resectable HCC
NCT06569498Resectable Hepatocellular Carcinoma
Fujian Provincial Hospital
Observational
20
Fuzhou, Xiamen, Zhangzhou
2024-09-30
By invitation
Clinical Trial of Anovulatory Infertility
NCT06601452Polycystic Ovary Syndrome, Diminished Ovarian Reserve, Ovulation Disorder
Affiliated Hospital of Nanjing University of Chinese Medicine
Phase EARLY_PHASE1
650
Nanjing
2024-09-30
Active, closed
Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06447636Gastric Cancer, Gastro Esophageal Junction Cancer
Fudan University
Phase 2
20
Shanghai
2024-09-30
Recruiting
A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
NCT06660992Non-cystic Fibrosis Bronchiectasis
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
669
Guangzhou, Yixingcun
2024-09-30
Not yet open
Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction
NCT06599801Oral Squamous Cell Carcinoma (OSCC)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
217
Guangzhou
2024-09-30
Recruiting
A Phase 2 Study of HB0017 in Psoriasis Patients
NCT06592274Psoriasis (PsO)
Huabo Biopharm Co., Ltd.
Phase 2
200
Bengbu, Guangzhou, Changsha, Wuxi, Zhenjiang, Changchun, Jinan, Jining
2024-09-30
Recruiting
A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
NCT06592989Pancreatic Neuroendocrine Neoplasm, Sorafenib, Gefitinib
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
20
Shanghai
2024-09-30
Recruiting
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)
NCT06590246Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.
Phase 1/2
121
Shanghai, Hanzhou
2024-09-30
By invitation
The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD
NCT07257588Ulcerative Colitis
Xijing Hospital of Digestive Diseases
Not applicable
44
Xi'an
2024-09-30
Recruiting
Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis
NCT06422845Arteriovenous Fistula Stenosis
DK Medical Technology (Suzhou) Co., Ltd.
Not applicable
328
Hefei, Beijing, Chongqing, Guanzhou, Huizhou, Shenzhen, Liuzhou, Nanning
2024-09-30
Not yet open
Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases
NCT06537297Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2
30
Changsha
2024-09-30
Not yet open
Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial
NCT06620822Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
296
Shanghai
2024-09-30
By invitation
The Trajectory and Influencing Factors of Cognitive Level in ICU Delirium Patients After Transfer Out of the ICU
NCT06674603Cognition Disorder, ICU, Delirium
Zunyi Medical College
Observational
240
Guiyang
2024-09-30
Recruiting
Construction of a Risky Sexual Behaviour Intervention Programme for College Students Based on BCW Theory
NCT06435234Unsafe Sex
Rong Zhang
Not applicable
40
Daqing
2024-09-29
Recruiting
Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
NCT06530303Colorectal Cancer, Colon Cancer, Rectum Cancer
Essen Biotech
Phase 1/2
85
Beijing
2024-09-29
Recruiting
Bactiseal Catheter Safety Registry Study
NCT06276543Hydrocephalus
Integra LifeSciences Corporation
Observational
200
Beijing, Guangzhou, Harbin, Wuhan, Shanghai, Chengdu
2024-09-29
Recruiting
A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With SSTR+ GEP-Nens
NCT06732505Neuroendocrine Neoplasm
Peking University Cancer Hospital & Institute
Phase 1
36
Beijing
2024-09-29
Recruiting
Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer
NCT05613452Non-small Cell Lung Cancer
Shanghai Proton and Heavy Ion Center
Phase 2
43
Shanghai
2024-09-29
Recruiting
Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
NCT06635681AML (Acute Myelogenous Leukemia)
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
380
Tianjin
2024-09-29
By invitation
โถโธGa-DPA in the Lung Cancer Diagnosis
NCT07023068Lung Cancers
Peking Union Medical College Hospital
Phase EARLY_PHASE1
40
Beijing
2024-09-28
Recruiting
Time Restricted Eating in Childhood Obesity (TRECO)
NCT06583447Childhood Obesity
Xiaoyan Shi
Not applicable
128
Suzhou
2024-09-28
Recruiting
Evaluation of the Effect of SURGICELยฎ Powder in TKA
NCT06608992Knee Osteoarthritis
Peking University Third Hospital
Phase 4
112
Beijing
2024-09-28
Active, closed
Effects of Parent-Adolescent Joint Interventions for Adolescents With Adverse Childhood Experiences
NCT06619821Stress, Emotional, Stress-related Mental Disorders, Adverse Childhood Experiences
Peking University
Not applicable
3,000
Baoding
2024-09-27
Recruiting
A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT06589778Non-Small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
124
Shanghai
2024-09-27
Recruiting
Brachial Versus Femoral Access for Carotid Artery Stenting
NCT06557135Carotid Artery Stenosis Without Infarction (Disorder), Ischemic Stroke
The First Affiliated Hospital with Nanjing Medical University
Not applicable
226
Nanjing
2024-09-27
Recruiting
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
NCT06562803Acute-On-Chronic Liver Failure, Sepsis
Third Affiliated Hospital, Sun Yat-Sen University
Not applicable
192
Guangzhou
2024-09-27
Recruiting
Exploration of Gender Differences in Liver Aging
NCT06591897Healthy Population
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
18
Hangzhou
2024-09-27
Recruiting
Study of Atrial Fibrillation Combined with Atrial Functional Mitral Regurgitation
NCT06630936Atrial Fibrillation (AF), Atrial Functional Mitral Regurgitation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
500
Hangzhou
2024-09-27
Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616Breast Cancer
Stemline Therapeutics, Inc.
Phase 3
4,220
2024-09-27
Recruiting
A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
NCT06564272Ewing Sarcoma
Beijing Konruns Pharmaceutical Co., Ltd.
Phase 2
30
Beijing
2024-09-27
By invitation
The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal Cancer
NCT06583564Colorectal Cancer Stage III
Shanghai Tong Ren Hospital
Not applicable
192
Changning
2024-09-27
Recruiting
Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma
NCT06194656Head and Neck Squamous Cell Carcinoma
Shanghai Institute Of Biological Products
Phase 2
81
Shanghai
2024-09-27
Active, closed
Effects of Parent-Adolescent Joint I-Interventions for Adolescents with Adverse Childhood Experiences
NCT06650696Stress-related Problem, Stress, Emotional
Peking University
Not applicable
200
Baoding
2024-09-27
Recruiting
A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases
NCT06970639NSCLC Patients With Brain Metastasis
Allist Pharmaceuticals, Inc.
Phase 3
380
Guangdong
2024-09-26
Recruiting
Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma
NCT06630780Head and Neck Squamous Cell Carcinoma (HNSCC)
Sun Yat-sen University
Not applicable
50
Guangzhou
2024-09-26
By invitation
A Phase โ…ก/โ…ข Study of Rulonilimab Plus Chemotherapyยฑ Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
NCT06755515Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD
Phase 2/3
510
Linyi
2024-09-26
Recruiting
The Feasibility of Pulmonary Perfusion Assessment Using Sodium Bicarbonate Contrast With Electrical Impedance Tomography: A Prospective Pilot Study
NCT07542366Acute Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Critical Illness
First Affiliated Hospital of Wannan Medical College
Observational
41
Wuhu
2024-09-26
By invitation
A Study to Evaluate the Safety and Efficacy of Staged Bilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor
NCT06676501Essential Tremor, Essential Tremor, Movement Disorders
Chinese PLA General Hospital
Not applicable
20
Beijing
2024-09-26
Active, closed
Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients
NCT06635447Breast Cancer
AstraZeneca
Phase 3
293
Baoding, Beijing, Bengbu, Changchun, Changsha, Chengdu, Dalian, Deyang
2024-09-26
Active, closed
A Study in Patients With Myasthenia Gravis in China
NCT06700616Myasthenia Gravis
AstraZeneca
Observational
1,199
Beijing, Chengdu, Fuzhou, Guangzhou, Guiyang, Harbin, Hebei, Henan
2024-09-26
Recruiting
Neck Observation or Elective Neck Dissection in cT1N0M0 OSCC
NCT06623266Oral Cancer, Lymph Node Metastasis
Huashan Hospital
Not applicable
300
Shanghai
2024-09-26
Not yet open
First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study
NCT06616259Colorectal Cancer (CRC), Capecitabine, Cetuximab
Meng Qiu
Phase 3
452
Chengdu
2024-09-26
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Zhenjiang, Xi'an, Shanghai
2024-09-26
Recruiting
A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
NCT06569056Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
578
Shanghai
2024-09-25
Not yet open
The Efficacy of Olfactory Training Intervention on Olfactory and Other Non-motor Symptoms in PD
NCT06607653Parkinson Disease, Olfactory Disorder, Olfactory Training
Anhui Medical University
Not applicable
40
Hefei
2024-09-25
Recruiting
Magnetoencephalography in Children
NCT06668519Epilepsy, Intracranial Tumors, Cerebrovascular Disease, Autism
Children's Hospital of Fudan University
Observational
1,500
Shanghai
2024-09-25
Recruiting
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
NCT06563245Classical Hodgkin Lymphoma, Child, Adolescent, Young Adult
Children's Cancer Group, China
Phase 2/3
96
Shanghai
2024-09-25
Recruiting
Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules
NCT06823895Healthy
Nanfang Hospital, Southern Medical University
Phase 1
12
Guangzhou
2024-09-25
Active, closed
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394Dravet Syndrome
Longboard Pharmaceuticals
Phase 3
96
Beijing, Guangzhou, Shenzhen Shi, Wuhan, Shanghai Shi
2024-09-25
Recruiting
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
NCT06568094Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
100
Harbin, Shanghai
2024-09-25
Recruiting
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
NCT06580301B-cell Acute Lymphoblastic Leukemia
Excyte Biopharma Ltd
Phase 1/2
46
Guangzhou, Guiyang, Zhengzhou, Xuzhou, Nanchang, Changchun, Dalian, Shenyang
2024-09-25
Recruiting
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects
NCT06669429Dyslipidemia
Peking University First Hospital
Phase 1
72
Beijing
2024-09-25
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
NCT06601010Pancreatic Cancer
Ruijin Hospital
Observational
30
Shanghai
2024-09-24
Recruiting
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
NCT06530251Hepatocellular Carcinoma
Akeso
Phase 1/2
280
Beijing, Jinan
2024-09-24
Recruiting
Pola-ZR2P in Previously Untreated DLBCL
NCT06664411Diffuse Large B-cell Lymphoma
Navy General Hospital, Beijing
Phase 2
80
Beijing
2024-09-24
Recruiting
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
NCT06569758Safety, Tolerability, GenSci098, Thyroid Eye Disease (TED)
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
76
Shanghai
2024-09-24
Recruiting
A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer
NCT06776861Advanced Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
150
Beijing
2024-09-24
Recruiting
RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure
NCT06663007Prostate Cancer, CDK12 Gene Mutation
Tianjin Medical University Second Hospital
Phase 1/2
72
Tianjin
2024-09-24
Recruiting
RC48 in Combination With AK104 and Bevacizumab in OCCC
NCT06540729Ovary Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
39
Guanzhou
2024-09-24
Active, closed
Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis
NCT06493279Amyotrophic Lateral Sclerosis Als
RJK Biopharma Ltd
Phase 1
9
Beijing
2024-09-24
Recruiting
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
NCT06775275Resectable Lung Non-Small Cell Carcinoma
The First Affiliated Hospital of Guangzhou Medical University
Phase 2
60
Guangzhou
2024-09-24
Recruiting
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
NCT06581640Multiple Myeloma, Relapsed/Refractory
The First Affiliated Hospital of Xiamen University
Phase 2
5
Xiamen
2024-09-24
Recruiting
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
NCT06577532Pancreatic Neoplasms, Other Solid Tumors
Ruijin Hospital
Phase EARLY_PHASE1
56
Shanghai
2024-09-24
Not yet open
TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
NCT06619886Solid Tumor, Adult, Lung Adenocarcinoma, Pancreas Cancer, Colorectal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
9
Shanghai
2024-09-24
Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease
NCT06650319Wilson Disease
Chaohui Yu
Phase EARLY_PHASE1
18
Hangzhou
2024-09-24
Recruiting
Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC
NCT06623578Papillary Thyroid Carcinoma, Lymphatic Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
876
Guangzhou
2024-09-23
Recruiting
Assessment of CT-FFR in Patients With CCS: A Prospective Multicenter Cohort Study
NCT07659119Coronary Artery Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
3,000
Hangzhou
2024-09-23
Recruiting
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
NCT06574360Schizophrenia
China Medical University Hospital
Phase 2
90
2024-09-23
Not yet open
Prediction of Stroke Risk in Patients with Atrial Fibrillation Based on Chest CT Images
NCT06611995Atrial Fibrillation (AF), Ischemic Stroke
First Affiliated Hospital of Zhejiang University
Observational
1,500
Hangzhou
2024-09-23
Recruiting
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy๏ผˆRECAST-MT๏ผ‰
NCT06559241Acute Ischemic Stroke, Anterior Circulation Brain Infarction
Capital Medical University
Phase 3
2,105
Suzhou, Taihe Chengguanzhen, Tongling, Beijing, Fuzhou, Zhangzhou, Shenzhen, Nanning
2024-09-23
Not yet open
A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight
NCT06606483Obesity, Overweight and Obesity
MindRank AI Ltd
Phase 2
300
Hefei, Xuancheng, Zibo, Beijing, Haikou, Shijiazhuang, Harbin, Luoyang
2024-09-23
Recruiting
Functional IOL Implantation in Patients With Epiretinal Membrane
NCT06719739Cataract, Intraocular Lens Complication, Epiretinal Membrane
Eye & ENT Hospital of Fudan University
Not applicable
90
Shanghai
2024-09-21
Recruiting
Target-specific immunoPET Imaging of Breast Cancer
NCT06715826Breast Cancer, Breast Neoplasms, Breast Cancer Metastatic
RenJi Hospital
Phase 1/2
200
Shanghai
2024-09-21
Recruiting
Combination of TURP and Standard Systemic Therapy for MPCa
NCT06655259Metastatic Prostate Cancer
Fudan University
Phase 2
200
Shanghai
2024-09-21
Recruiting
The Efficacy of Allo-HSCT in ND HR-CBF-AML
NCT06458244Acute Myeloid Leukemia
Ruijin Hospital
Observational
90
Shanghai
2024-09-21
Active, closed
Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control
NCT06667037Myopia
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
112
Guangzhou
2024-09-21
Recruiting
The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis
NCT06609447Ulcerative Colitis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
100
Beijing, Chongqing, Guangzhou, Wuhan, Xiโ€™an, Chengdu, Hangzhou, Huzhou
2024-09-21
Recruiting
U87 CAR-T in Patients With Advanced Head and Neck Tumors
NCT06614686Nasopharynx Cancer, Head and Neck Cancer
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1
20
Shanghai
2024-09-20
Recruiting
Uterine Round Ligament Preservation Vs Resection in Laparoscopic Inguinal Hernia Repair in Women๏ผšA Multicenter,Stratified Randomized Controlled Trial
NCT06885788Inguinal Hernia, Laparoscopic Surgery, Randomized Controlled Trial
Nanchong Central Hospital
Not applicable
466
Nanchong
2024-09-20
Recruiting
2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
NCT06492460Squamous Cell Carcinoma of Head and Neck
Sun Yat-sen University
Phase 3
422
Guangzhou, Guilin, Changsha, Nanjing
2024-09-20
Not yet open
Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine
NCT06613659Community-Acquired Infections
Henan University of Traditional Chinese Medicine
Observational
1,016
Zhengzhou
2024-09-20
Not yet open
CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML
NCT06470841Acute Myeloid Leukemia
Navy General Hospital, Beijing
Phase 2
85
Beijing
2024-09-20
Recruiting
Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE
NCT06607276Cholangiocarcinoma Cancer, Adebrelimab (SHR-1316)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
122
Nanjing, Xuzhou, Yancheng
2024-09-20
Active, closed
EGM Guided PFA for PerAF
NCT06729866Persistent Atrial Fibrillation
Xu Liu
Not applicable
58
Shanghai
2024-09-20
Recruiting
Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis
NCT05860569Hypertriglyceridemia, Familial
GeneCradle Inc
Phase 1
7
Beijing
2024-09-20
Recruiting
Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC
NCT06592755Papillary Thyroid Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
120
Guangzhou
2024-09-20
Not yet open
The Effect of Aromatherapy for First Dental Visit Patients
NCT06598904Dental Anxiety
Sichuan University
Not applicable
120
Chengdu
2024-09-20
Not yet open
Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC
NCT06599827Rectal Cancer
Shanghai Zhongshan Hospital
Phase 2
54
Shanghai
2024-09-20
Recruiting
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
NCT06469944Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
Merck Sharp & Dohme LLC
Phase 1/2
160
Beijing, Fuzhou, Xiamen, Zhengzhou, Nanchang, Shanghai, รœrรผmqi, Hangzhou
2024-09-20
Recruiting
Hydration Guided by Remote Dielectric Sensing (ReDS) System for Preventing Acute Kidney Injury in Elderly Patients With Renal Insufficiency for Coronary Angiography and Intervention
NCT07394959Coronary Artery Disease, Chronic Kidney Disease, Elderly
Chinese PLA General Hospital
Not applicable
320
Beijing
2024-09-20
By invitation
Correlation Between Gut Microbiota and Pancreatic ฮ’-Cell Function in Diabetic Patients
NCT06645223Diabetes Mellitus, Gut Microbiota
Peking University Third Hospital
Observational
160
Beijing
2024-09-20
Not yet open
Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients
NCT06592625Untreated Early-stage or Locally Advanced Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
60
Beijing
2024-09-20
Recruiting
Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy
NCT06749639Inherited Retinal Diseases
Peking Union Medical College Hospital
Phase EARLY_PHASE1
10
Beijing
2024-09-20
Not yet open
To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection
NCT06561594Idiopathic Hypogonadotropic Hypogonadism
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
60
Hefei, Beijing, Guangzhou, Shenzhen, Zhengzhou, Wuhan, Nanjing, Nanchang
2024-09-20
Recruiting
A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
NCT07299825Her 2 Positive Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
40
Zhenzhou
2024-09-20
Recruiting
Blinatumomab for CNI-Resistant/Intolerant SRNS in Children
NCT06607991CNI-resistant Steriod Resistant Nephrotic Syndrome, CNI-intolerent, Steriod Resistant Nephrotic Syndrome, Multidrug Resistant Nephrotic Syndrome
The Children's Hospital of Zhejiang University School of Medicine
Phase 1
6
Hangzhou
2024-09-19
Rows per page Showing 11401–11500 of 19052
Previous 113 114 115 116 117 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=115

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.